Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518070/
https://www.ncbi.nlm.nih.gov/pubmed/27872948
http://dx.doi.org/10.1007/s00125-016-4146-6
_version_ 1783418387324469248
collection PubMed
description
format Online
Article
Text
id pubmed-6518070
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65180702019-06-05 Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes Diabetologia Position Statement Springer Berlin Heidelberg 2016-11-21 2017 /pmc/articles/PMC6518070/ /pubmed/27872948 http://dx.doi.org/10.1007/s00125-016-4146-6 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Position Statement
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title_full Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title_fullStr Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title_full_unstemmed Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title_short Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
title_sort glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the american diabetes association and the europian association for the study of diabetes
topic Position Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518070/
https://www.ncbi.nlm.nih.gov/pubmed/27872948
http://dx.doi.org/10.1007/s00125-016-4146-6
work_keys_str_mv AT glucoseconcentrationsoflessthan30mmoll54mgdlshouldbereportedinclinicaltrialsajointpositionstatementoftheamericandiabetesassociationandtheeuropianassociationforthestudyofdiabetes

Ejemplares similares